Semler Scientific, Inc. (NASDAQ:SMLR) is considered one of the best medical device stocks to buy by analysts. Analyst Matthew Galinko of Maxim Group maintained a Buy rating on SMLR with a price target of $95.00. The company aims to accumulate 10,000 BTC by the end of 2025, and more in the following years, supported by a strong financial strategy and the formation of CardioVanta, a subsidiary focused on cardiovascular market opportunities. Semler Scientific provides technology and software solutions to improve clinical effectiveness for healthcare providers, offering a multi-test service platform, WellChec, that evaluates patients for chronic diseases. While SMLR shows potential as an investment, certain AI stocks may offer greater upside potential.

Read more at Yahoo Finance: Maxim Group Maintains a Buy Rating on Semler Scientific (SMLR), Sets a $95 PT